• Explore /
  • Poster
  • / Circulating tumor cell (CTC) enumeration in patients (pts) with metastatic genitourinary (mGU) tumors treated in a phase I study of cabozantinib and nivolumab (CaboNivo) +/- ipilimumab (CaboNivoIpi).

Circulating tumor cell (CTC) enumeration in patients (pts) with metastatic genitourinary (mGU) tumors treated in a phase I study of cabozantinib and nivolumab (CaboNivo) +/- ipilimumab (CaboNivoIpi).

Abstract Poster

Authors

null

Zishuo Hu

National Institute of Health, Bethesda, MD

Zishuo Hu , Amir Mortazavi , Sumanta K. Pal , Primo Lara Jr., Tina M. Mayer , Seth M Steinberg , Christian Mayfield , Katherine Graap , Marissa Mallek , Rene Costello , Carlos Diaz , Joseph Schonhoft , Yipeng Wang , Ryan Dittamore , Lincy Chu , Jane B Trepel , Donald P. Bottaro , Andrea B. Apolo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Urothelial Carcinoma

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 379)

DOI

10.1200/JCO.2019.37.7_suppl.379

Abstract #

379

Poster Bd #

F14

Abstract Disclosures

Similar Posters

First Author: Andrea B. Apolo

First Author: Nicholas I. Simon

First Author: Pui Ying Chan

First Author: Juan José Soto